Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacomechanical Catheter-directed Thrombolysis (PCDT) Plus Anticoagulation Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis:

NCT04411316 is registered in ClinicalTrials.gov with University of Toledo Health Science Campus as lead sponsor.

NCT NCT04411316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04411316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacomechanical Catheter-directed Thrombolysis (PCDT) Plus Anticoagulation Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis:
Lead sponsor
University of Toledo Health Science Campus
Phase
Phase 4
Overall status
Withdrawn
Start date
December 19, 2019
Completion date
December 19, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep venous thrombosis, post thrombotic syndrome